研究Research

研究業績一覧

英文

2023年

  • Efficacy and Safety of Cefmetazole for Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacterales vs Carbapenems: A Retrospective Study
    Kashihara E.; Sada R.M.; Tsugihashi Y.; Obayashi H.; Nakamura A.; Abe N.; Miyake H.; Akebo H.
    Open Forum Infectious Diseases. 2023;10(10), ofad502
  • Prevalence and factors associated with polypharmacy among patients with rheumatoid arthritis: a single-centre, cross-sectional study
    Miyake H.; Sada R.M.; Akebo H.; Tsugihashi Y.; Hatta K.
    Clinical Rheumatology. 2023;42(9), pp. 2287–2295
  • Factors and Reasons for Non-vaccination among Patients with Systemic Lupus Erythematosus: A Single-centre, Cross-sectional Study
    Miyake H.; Sada R.M.; Manabe A.; Tsugihashi Y.; Hatta K.
    Internal Medicine. 2023;62(17), pp. 2483–2491
  • Prime-boost-type PspA3 + 2 mucosal vaccine protects cynomolgus macaques from intratracheal challenge with pneumococci
    Yokota C.; Fujimoto K.; Yamakawa N.; Kono M.; Miyaoka D.; Shimohigoshi M.; Uematsu M.; Watanabe M.; Kamei Y.; Sugimoto A.; Kawasaki N.; Yabuno T.; Okamura T.; Kuroda E.; Hamaguchi S. et al.
    Inflammation and Regeneration.2023;43(1), 55
  • Establishment of a modified opsonophagocytic killing assay for anti-pneumococcal surface protein A antibody
    Kuroda E.; Koizumi Y.; Piao Z.; Nakayama H.; Tomono K.; Oishi K.; Hamaguchi S.; Akeda Y.
    Journal of Microbiological Methods.2023; 212, 106804
  • Negative effects of pre-admission screening with simplified multiplex PCR
    Suzuki Y.; Kusama Y.; Ito Y.
    Pediatrics International.2023;65(1), e15629
  • Protocol for a Randomized, Open-Label Clinical Trial on the Effect of Mouthwash on Salivary SARS-CoV-2 Load
    Konishi K.; Onozuka D.; Takatera S.; Matsuo H.; Yoshida H.; Hamaguchi S.; Yamamoto S.; Sada R.M.; Suzuki K.; Kutsuna S.
    Life.2023;13(12), 2312
  • Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved
    Suzuki T., Asai Y., Takahashi K., Sanada M., Shimanishi Y., Terada M., Sato L., Inada M., Yamada G., Akiyama Y., Oshiro Y., Shiratori K., Togano T., Takamatsu Y., Kenji M., Matsunaga A., Ishizaka Y.,  Kutsuna S., et al.
    Heliyon.2023;9(10), e20568
  • Evaluation of potential rabies exposure among Japanese international travelers: A retrospective descriptive study
    Nomoto H., Yamamoto K., Kutsuna S., Asai Y., Kasamatsu Y., Shirano M., Sahara T., et al.
    PLoS ONE.2023;18(8 AUGUST), e0287838
  • Aneurysm Infection Caused by Desulfovibrio desulfuricans
    Fujihara T., Kimura K., Matsuo H., Sada R.M., Hamaguchi S., Yamamoto G., Yamakura T., Kutsuna S.
    Emerging Infectious Diseases.2023;29(8), pp. 1680–1681
  • Evaluation Antibacterial and Bactericidal Properties of Si Nanopillars Array Against Antimicrobial Resistant (AMR) Bacteria
    Yanagisawa Y., Yamamoto G., Hamaguchi S., Shimizu T., Shingubara S., Kutsuna S., Ito T.
    Proceedings of the IEEE Conference on Nanotechnology.2023;July, pp. 1014–1017
  • The safety of plasma apheresis from donors recovering from COVID-19 infection in Japan
    Kamo-Imai A., Togano T., Sato M., Kawakami Y., Inaba K., Shimazu H., Igarashi S., Tanaka K., Terada M., Kinoshita-Iwamoto N., Saito S., Kutsuna S., et al.
    Transfusion and Apheresis Science.2023;62(3), 103687
  • Epidemiology of post-COVID conditions beyond 1 year: a cross-sectional study
    Morioka S., Tsuzuki S., Maruki T., Terada M., Miyazato Y., Kutsuna S., Saito S., Shimanishi Y., et al.
    Public Health.2023;216, pp. 39–44
  • Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial
    Saito S., Kutsuna S., Akifumi I., Hase R., Oda R., Terada J., Shimizu Y., Uemura Y., Takamatsu Y., et al.
    Journal of Infection and Chemotherapy.2023;29(9), pp. 869–874
  • Nasopharyngeal SARS-CoV-2 may not be dispersed by a high-flow nasal cannula
    Suzuki T., Morioka S., Yamamoto K., Saito S., Iida S., Teruya K., Takasaki J., Hojo M., Kutsuna S., et al.
    Scientific Reports.2023;13(1), 2669
  • Comparison of the clinical characteristics and outcomes of Japanese patients with COVID-19 treated in primary, secondary, and tertiary care facilities
    Tomidokoro D., Asai Y., Hayakawa K., Kutsuna S., Terada M., Sugiura W., Ohmagari N., Hiroi Y.
    Journal of Infection and Chemotherapy.2023;29(3), pp. 302–308
  • Deprescribing antacids after the diagnosis of Clostridioides difficile infection: A single-center observational study
    Okamoto K., Harada T., Kosaka S., Kutsuna S.
    Journal of Infection and Chemotherapy.2023;29(2), pp. 232–234
  • Steroid pulse therapy for severe fever with thrombocytopenia syndrome patients may not improve prognosis: Retrospective analysis with overlap weighting using a national inpatient database
    Kutsuna S., Ohbe H., Matsui H., Yasunaga H.
    Journal of Infection and Chemotherapy.2023;29(5), pp. 490–494
  • Nationwide Descriptive Epidemiological Study of Patients with COVID-19 Evacuated from Wuhan, China to Japan from January to February, 2020
    Nomoto H., Ishikane M., Gu Y., Yamamuro R., Osawa R., Hosokawa N., Sahara T., Nakamura-Uchiyama F., Fukushima K., Sekiya N., Imamura A., Fujikura Y., Kawana A., Nagata K., Tamura K., Kutsuna S., Ohmagari N.
    Japanese Journal of Infectious Diseases.2023;76(1), pp. 20–26
  • Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma
    Inada M., Togano T., Terada M., Shiratori K., Tsuzuki S., Takamatsu Y., Saito S., Hangaishi A., Morioka S., Kutsuna S., Maeda K., Mitsuya H., Ohmagari N.
    Transfusion and Apheresis Science.2023;62(3), 103638

2022年

  • Bacillus subtilis variant natto Bacteremia of Gastrointestinal Origin, Japan.
    Tanaka I, Kutsuna S, Ohkusu M, Kato T, Miyashita M, Moriya A, et al.
    Emerging infectious diseases. 2022;28(8):1718-1719
  • Cardiovascular complications of hospitalized patients with coronavirus disease 2019 in a Japanese registry in 2020
    Hiroi Y, Ohtsu H, Uemura Y, Hayakawa K, Asai Y, Kutsuna S, et al.
     Circulation Journal. 2022;86(3):464-471
  • Catheter-related bloodstream infection caused by Tsukamurella ocularis: A case report
    Kawashima A, Kutsuna S, Shimomura A, Suzuki T, Nakamoto T, Ando H, et al.
     Journal of Infection and Chemotherapy. 2022;28(3):434-436
  • Clinical performance testing of the automated haematology analyzer XN-31 prototype using whole blood samples from patients with imported malaria in Japan
    Komaki-Yasuda K, Kutsuna S, Kawaguchi M, Kamei M, Uchihashi K, Nakamura K, et al.
    Malaria journal. 2022;21(1)
  • Delayed Tetracycline Initiation Increases Mortality Risk in Patients With Japanese Spotted Fever: Retrospective Analysis Using a National Inpatient Database
    Kutsuna S, Ohbe H, Matsui H, Yasunaga H,
     Open Forum Infectious Diseases; 2022: 9(11):ofac573
  • Effectiveness of fluoroquinolone antimicrobials in addition to tetracyclines for Japanese spotted fever: A retrospective analysis using a national inpatient database
    Kutsuna S, Ohbe H, Matsui H, Yasunaga H.
     International Journal of Infectious Diseases. 2022;123:70-5
  • Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 panel, a rapid multiplex PCR method for the diagnosis of COVID-19
    Ishikane M, Unoki-Kubota H, Moriya A, Kutsuna S, Ando H, Kaburagi Y, et al.
     Journal of Infection and Chemotherapy. 2022;28(6):729-734
  • Factors associated with development and persistence of post-COVID conditions: A cross-sectional study
     Miyazato Y, Tsuzuki S, Morioka S, Terada M, Kutsuna S, Saito S, et al.
    Journal of Infection and Chemotherapy. 2022;28(9)1242-1248
  • Impact of the COVID-19 pandemic on racial and ethnic minorities in Japan
    Nomoto H, Asai Y, Hayakawa K, Matsunaga N, Kutsuna S, Kodama EN, Ohmagari N.
     Epidemiology & Infection. 2022;150:e202
  • Imported African Tick Bite Fever in Japan: A Literature Review and Report of Three Cases
    Ando N, Kutsuna S, Takaya S, Katanami Y, Ohmagari N.
    Internal Medicine. 2022;61(7):1093-1098.
  • Interleukin-6 is upregulated and may be associated with myocardial injury in some patients who have recovered from COVID-19.
     Hayama H, Ide S, Kitami Y, Hara H, Kutsuna S, Hiroi Y.
    Global health & medicine. 2022;4(1):61-3.
  • A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)
    Tomita N, Saito S, Terada-Hirashima J, Mikami A, Uemura Y, Kutsuna S, et al.
     Life. 2022;12(6):856.
  • Safety of convalescent plasma therapy for COVID-19 patients and analysis of viral kinetics: a single-center, open-label, single-arm, interventional study in Japan.
    Kutsuna S, Saito S, Takamatsu Y, Terada M, Togano T, Kinoshita N, et al.
    GHM Open. 2022.
  • Streptobacillus notomytis Bacteremia after Exposure to Rat Feces 
    Kawashima A, Kutsuna S, Shimomura A, Sato L, Ando H, Tanikawa T, Nagashima M, Miyoshi-Akiyama T, Inagaki T, Ohmagari N.   
     Emerging Infectious Diseases. 2022;28(4):886-888
  • Association between serum alkaline phosphatase and bacteraemia in haemodialysis outpatients: a multicentre retrospective cross-sectional study 
     Katasako A, Sasaki S, Raita Y, Yamamoto S, Tochitani K, Murakami M, Nishioka R, Fujisaki K. 
     BMJ Open. 2022 Oct 7;12(10):e058666.
  • Comparison of extraction-based and elution-based polymerase chain reaction testing, and automated and rapid antigen testing for the diagnosis of severe acute respiratory syndrome coronavirus 2.
    Yoshioka N, Deguchi M, Hagiya H, Kagita M, Tsukamoto H, Takao M, Yoshida H, Hamaguchi S, Maeda I, Hidaka Y, Tomono K.
    J Med Virol. 2022 Jul;94(7):3155-3159. doi: 10.1002/jmv.27709. Epub 2022 Mar 22.
  • Immunogenicity of SARS‐CoV‐2 vaccination in adolescents with cardiac disease
    Hayashi H,Narita J,Ishii R, Hirose M, Hashimoto K,Yamagishi Y,Ozono K, Nakagami H, Ishida H
    Pediatrics International (2022)64, e15329
  • Safety evaluation of MA-T after ingestion in mice.
    Noguchi T, Tachibana K, Inoue T,Sakai T, Tsujikawa K,Fujio Y, Yamagishi Y, Hamaguchi S, Kutsuna S, Kondoh M
    Toxicology 477 Jul: 153254

2021年

  • Catheter-related bloodstream infection caused by Tsukamurella ocularis: A case report      Kawashima A, Kutsuna S, Shimomura A, Suzuki T, Nakamoto T, Ando H, Nagashima M, Inagaki T, Ohmagari N.                                                Journal of Infection and Chemotherapy.28(3):434-436
  • Effects of message order and active participation on vaccine risk communication.
    Okuno H, Satoh H, Iitake C, Hosokawa S, Oishi K, Kikkawa T.
    Pediatr Int. 2021 Nov;63(11):1363-1368. doi: 10.1111/ped.14662. Epub 2021 Sep 30. PMID: 33599373.
  • Combining machine learning and nanopore construction creates an artificial intelligence nanopore for coronavirus detection.
    Taniguchi M, Minami S, Ono C, Hamajima R, Morimura A, Hamaguchi S, Akeda Y, Kanai Y, Kobayashi T, Kamitani W, Terada Y, Suzuki K, Hatori N, Yamagishi Y, Washizu N, Takei H, Sakamoto O, Naono N, Tatematsu K, Washio T, Matsuura Y, Tomono K.
    Nat Commun. 2021 Jun 17;12(1):3726.
  • Mechanisms Underlying Pneumococcal Transmission and Factors Influencing Host-Pneumococcus Interaction: A Review.
    Morimura A, Hamaguchi S, Akeda Y, Tomono K.
    Front Cell Infect Microbiol. 2021 Apr 28;11:639450.
  • 10-Year survey on serum antibody positivity rates and titers for measles and rubella in healthcare workers; an observational study at a Japanese university hospital.
    Yoshioka N, Deguchi M, Hagiya H, Kagita M, Tsukamoto H, Takao M, Yoshida H, Hamaguchi S, Maeda I, Hidaka Y, Tomono K.
    J Infect Chemother. 2021 Sep;27(9):1295-1299.
  • Multiplex Real-Time PCR Assay for Six Major Carbapenemase Genes.
    Yoshioka N, Hagiya H, Deguchi M, Hamaguchi S, Kagita M, Nishi I, Akeda Y, Tomono K.
    Pathogens. 2021 Mar 1;10(3):276.
  • Deskilled and Rapid Drug-Resistant Gene Detection by Centrifugal Force-Assisted Thermal Convection PCR Device.
    Espulgar WV, Saito M, Takahashi K, Ushiro S, Yamamoto N, Akeda Y, Hamaguchi S, Tomono K, Tamiya E.
    Sensors (Basel). 2021 Feb 9;21(4):1225.
  • The characteristics and clinical course of patients with COVID-19 who received invasive mechanical ventilation in Osaka, Japan.
    Hirayama A, Masui J, Murayama A, Fujita S, Okamoto J, Tanaka J, Hirayama T, Ohara T, Hoffmann EN, Zhang J, Kawachi H, Okuno H, Hamaguchi S, Tomono K, Asada R.
    Int J Infect Dis. 2021 Jan;102:282-284.

2020年

  • Economic impact of antimicrobial-resistant bacteria outbreaks on Japanese hospitals.
    Morii D, Tomono K, Imanaka Y.
    Am J Infect Control. 2020 Oct;48(10):1195-1199.
  • Risk for the occupational infection by cytomegalovirus among health-care workers.
    Takao M, Yoshioka N, Hagiya H, Deguchi M, Kagita M, Tsukamoto H, Hidaka Y, Tomono K, Tobe T.
    J Infect Chemother. 2020 Jul;26(7):681-684.
  • Serial change of neutrophil extracellular traps in tracheal aspirate of patients with acute respiratory distress syndrome: report of three cases.
    Ojima M, Yamamoto N, Hirose T, Hamaguchi S, Tasaki O, Kojima T, Tomono K, Ogura H, Shimazu T.
    J Intensive Care. 2020 Apr 10;8:25
  • Repeated Chest Computed Tomography Revealed Early-stage Miliary Tuberculosis.
    Okuno H, Hagiya H, Hamaguchi S, Tomono K.
    Intern Med. 2020 Feb 1;59(3):461-462.
  • Mycobacterium kansasii arthritis of the elbow in an immunocompetent patient with a suspected soft-tissue tumor.
    Okuno H, Tanaka H, Hagiya H, Yoshida H, Hamaguchi S, Hori Y, Morii E, Hamada K, Yoshikawa H, Tomono K.
    J Infect Chemother. 2020 Feb;26(2):261-264.
  • Rapid multiplex detection of the resistance genes mecA, vanA and vanB from Gram-positive cocci-positive blood cultures using a PCR-dipstick technique.
    Shanmugakani RK, Fujiya Y, Akeda Y, Hamaguchi S, Hamada S, Tomono K.
    J Med Microbiol. 2020 Feb;69(2):249-255.

邦文

  • 日本国内で開発され、米国で臨床試験が行われていない抗菌薬の用法用量に関するアンケート調査      日馬由貴,町田尚子, 松尾裕央, 山岸義晃,忽那賢志                          日本化学療法学会雑誌,2024
  • 【ミミッカー症例からいかに学ぶか】ミミッカーに騙されないための方略とは               佐田 竜一                                              日本化学療法学会雑誌,Vol.71 no.4::415-416,2023.07
  • 効果的なICTラウンド活動~継続的な評価と現場を支える活動~
    太田悦子,長田麻友子,吉田寿雄,吉岡範,小門諒平,鍋谷佳子
    環境感染誌 , Vol.36 no.4 : 196-204, 2021.